Single-anastomosis Sleeve Jejunal: a Mid-term Follow-up Report of a New Surgical Technique

Rezaei, Mohammad Taghi; Sheikhbahaei, Erfan; Zefreh, Hamidreza; Allami, Mostafa; Shahraki, Masoud Sayadi; Shahabi, Shahab

doi:10.1007/s11695-023-06520-7

Cited by 4 publications

(20 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Three studies were non-randomized clinical trials [ 24 , 28 , 29 ], two studies were randomized clinical trials [ 25 , 26 ], three studies were retrospective cohorts [ 18 , 27 , 30 ], and one study was a prospective cohort [ 19 ]. The studies were conducted in Iran [ 24 , 27 , 30 ] and Egypt [ 18 , 19 , 25 , 26 , 28 , 29 ]. Patients were mostly females, with males representing only 14-34.9% of the sample size.…”

Section: Reviewmentioning

confidence: 99%

“… Sayadishahraki et al [ 24 ]; Sewefy and Saleh [ 19 ]; Helmy et al [ 26 ]; Hosseini et al [ 27 ]; Sewefy et al [ 18 ]; Rezaei et al [ 30 ]. …”

Section: Reviewmentioning

confidence: 99%

“…Five studies reported BMI at 12 months after SASJ [ 18 , 19 , 26 , 27 , 30 ] (Table 3 ). There was significant heterogeneity, so the random effects model was used to pool the results (Q = 519.313, p < 0.001, I² = 99.23%).…”

Section: Reviewmentioning

confidence: 99%

“…Three studies reported mean %TWL at six months after SASJ bypass [ 25 , 28 , 30 ] (Table 3 ). Significant heterogeneity existed among the studies (Q = 12.972, p = 0.002, I² = 84.58%), and the results were pooled using the random effects model.…”

Section: Reviewmentioning

confidence: 99%

“… Sayadishahraki et al [ 24 ]; Helmy et al [ 26 ]; Hosseini et al [ 27 ]; Sewefy et al [ 18 ]; Elrefai et al [ 25 ]; Abdelzaher et al [ 28 ]; Rezaei et al [ 30 ]; Sewefy and Saleh [ 19 ]; Farrag et al [ 29 ]. …”

Section: Reviewmentioning

confidence: 99%

See 4 more Smart Citations

Single-Anastomosis Sleeve Jejunal Bypass as a Treatment for Morbid Obesity: A Systematic Review and Meta-Analysis

Alenezi,

Alkhaldi,

Alrumaih

et al. 2023

Cureus

View full text Add to dashboard Cite

Single-anastomosis sleeve jejunal (SASJ) bypass is a bariatric surgery technique with promising results. However, evidence of its efficacy and safety is still lacking. This study aimed to summarize the evidence regarding the efficacy and safety of SASJ bypass surgery in the treatment of morbid obesity. The literature was searched for English-language studies published from inception till November 26, 2023, on MEDLINE/PubMed, Cochrane Library, Web of Science, ProQuest, Scopus, SCINAPSE, and Google Scholar. The search terms included “morbid obesity,” “bariatric surgery,” and “single anastomosis sleeve jejunal bypass.” Extracted data included the body mass index (BMI) before and after surgery, percent total weight loss (%TWL), percent excess weight loss (%EWL), and improvement in preoperative comorbidities. Pooling of the data was done using random effects or fixed-effect models based on the presence of significant heterogeneity. Nine studies were included in this systematic review and meta-analysis. The change in BMI from baseline at 12 months after SASJ bypass was significant (standardized mean difference (SMD) = -3.576, 95% confidence interval (CI) = -5.423, -1.730; I² = 99.23%). At 12 months after surgery, the pooled %TWL was 42.526 (95% CI = 37.948, 47.105; I² = 97.15%), and the pooled %EWL was 75.258 (95% CI = 67.061, 83.456; I² = 99.26%). The pooled incidence of postoperative improvement in diabetes mellitus was 91% (95% CI = 79.6%, 98%, I² = 82%). The overall rate of complications was 9.9% (95% CI = 2.5%, 21.6%; I² = 92.64%). Regarding the short- and mid-term outcomes, SASJ bypass is a safe and effective procedure for weight loss in patients with morbid obesity, with an acceptable rate of complications. The procedure is also associated with a marked improvement in obesity-related comorbidities.

show abstract